1-3 of 3
Paolo Milani
Close
Sort by
Journal Articles

Search for AL amyloidosis risk factors using Mendelian randomization

Charlie N. Saunders, Subhayan Chattopadhyay, Stefanie Huhn, Niels Weinhold, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O. Schönland, Asta Försti, Richard Houlston, Kari Hemminki
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2725–2731.
https://doi.org/10.1182/bloodadvances.2021004423
Published: 2021
Includes: Supplemental data
Journal Articles

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Clinical Trials & Observations
Marco Basset, Paolo Milani, Mario Nuvolone, Francesca Benigna, Lara Rodigari, Andrea Foli, Giampaolo Merlini, Giovanni Palladini
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4175–4179.
https://doi.org/10.1182/bloodadvances.2020002219
Published: 2020
Includes: Supplemental data
Journal Articles

Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function

Clinical Trials & Observations
Paolo Milani, Marco Basset, Paola Curci, Andrea Foli, Rita Rizzi, Mario Nuvolone, Raffaella Guido, Loreto Gesualdo, Giorgina Specchia, Giampaolo Merlini, Giovanni Palladini
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1321–1324.
https://doi.org/10.1182/bloodadvances.2020001553
Published: 2020
Includes: Supplemental data